August 2025
1. KARIMI A, Lieber CM, Sakamoto K, Plemper RK, et al
   SARS-CoV-2 causes chronic lung inflammation and impaired respiratory capacity in aged Roborovski dwarf hamsters.
   J Virol. 2025 Aug 11:e0075525. doi: 10.1128/jvi.00755.
   

   >> Share

   
   April 2025
2. HUANG Y, Liang G, Wang T, Ma Y, et al
   Research strategies of the N-peptide fusion inhibitor: a promising direction for discovering novel antivirals.
   J Virol. 2025 Apr 10:e0228924. doi: 10.1128/jvi.02289.
   

   >> Share

   
   March 2025
3. HSIEH S-H, Huang K-J, Wang C-T
   A virus-like particle assembly system for probing the HIV-1 Gag-Pol dimerization domain: supporting evidence for reverse transcriptase involvement in protease activation by influencing Gag-Pol/Gag-Pol interaction.
   J Virol. 2025 Mar 12:e0223624. doi: 10.1128/jvi.02236.
   

   >> Share

   
   February 2025
4. JANSSENS J, Wedrychowski A, Kim SJ, Isbell C, et al
   Longitudinal changes in the transcriptionally active and intact HIV reservoir after starting ART during acute infection.
   J Virol. 2025 Feb 5:e0143124. doi: 10.1128/jvi.01431.
   

   >> Share

   
   
5. PHAN T, Ribeiro RM, Edelstein GE, Boucau J, et al
   Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance.
   J Virol. 2025 Feb 4:e0162324. doi: 10.1128/jvi.01623.
   

   >> Share

   
   December 2024
6. TAKAHAMA S, Washizaki A, Okamura T, Kitamura S, et al
   The quality of SIV-specific fCD8 T cells limits SIV RNA production in Tfh cells during antiretroviral therapy.
   J Virol. 2024 Dec 6:e0081224. doi: 10.1128/jvi.00812.
   

   >> Share

   
   August 2024
7. LIEBER CM, Kang H-J, Sobolik EB, Sticher ZM, et al
   Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection.
   J Virol. 2024 Aug 29:e0090524. doi: 10.1128/jvi.00905.
   

   >> Share

   
   October 2023
8. KUSE N, Gatanaga H, Zhang Y, Chikata T, et al
   Epitope-dependent effect of long-term cART on maintenance and recovery of HIV-1-specific CD8(+) T cells.
   J Virol. 2023 Oct 25:e0102423. doi: 10.1128/jvi.01024.
   

   >> Share

   
   September 2023
9. HSIEH SH, Yu FH, Huang KJ, Wang CT, et al
   HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation.
   J Virol. 2023 Sep 6:e0094823. doi: 10.1128/jvi.00948.
   

   >> Share

   
   April 2023
10. ZHANG L, Yang J, Li H, Zhang Z, et al
    Enterovirus D68 Infection Induces TDP-43 Cleavage, Aggregation, and Neurotoxicity.
    J Virol. 2023 Apr 11:e0042523. doi: 10.1128/jvi.00425.
    

    >> Share

    
    December 2022
11. KIM S, Filsinger Interrante MV, Kim PS
    Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies.
    J Virol. 2022 Dec 21:e0164722. doi: 10.1128/jvi.01647.
    

    >> Share

    
    July 2022
12. RATCLIFF AN, Venner CM, Olabode AS, Knapp J, et al
    Enhancement of CD4 Binding, Host Cell Entry, and Sensitivity to CD4bs Antibody Inhibition Conferred by a Natural but Rare Polymorphism in the HIV-1 Envelope.
    J Virol. 2022 Jul 5:e0185121. doi: 10.1128/jvi.01851.
    

    >> Share

    
    June 2022
13. PEDERSEN SF, Collora JA, Kim RN, Yang K, et al
    Inhibition of a Chromatin and Transcription Modulator, SLTM, Increases HIV-1 Reactivation Identified by a CRISPR Inhibition Screen.
    J Virol. 2022 Jun 22:e0057722. doi: 10.1128/jvi.00577.
    

    >> Share

    
    November 2021
14. WU C, He Y, Zhao J, Luo K, et al
    Exacerbated AIDS progression by PD-1 blockade during therapeutic vaccination in chronically SIV-infected rhesus macaques after ART treatment interruption.
    J Virol. 2021 Nov 24:JVI0178521. doi: 10.1128/JVI.01785.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share